1)- Hong Wang, Yan-Jie Li, Lin Lei, Cheng-Cheng Liu, Wan-Qing Chen, Min Dai, Xin Wang, Jie-Bin Lew, Ju-Fang Shi, Ni Li, Jie He. Estimating the economic burden of colorectal cancer in China, 2019-2030: A population-level prevalence-based analysis.Cancer medicine. 2023, :
2)- Elisabeth de Kermadec, Yue Zheng, Shoshana Rosenberg, Kathryn J Ruddy, Jennifer A Ligibel, Karen M Emmons, Ann H Partridge. Fertility concerns and treatment decision-making among national sample of young women with breast cancer.Cancer medicine. 2023, :
4)- Jennifer L Moss, Savanna G Ledford, Veronica Bernacchi, Chan Shen. Hospital- and county-level characteristics explain geographic variability in prices of cancer-related procedures: Implications for policy and interventions.Cancer medicine. 2023, :
8)- Cecilia Monge, Tim F Greten. Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 years.Cancer medicine. 2023, :
9)- Huiping Shi, Liang Gao, Hong Yin, Min Jiang. BLM mutation is associated with increased tumor mutation burden and improved survival after immunotherapy across multiple cancers.Cancer medicine. 2023, :
11)- Xinglin Yi, Yi He, Gangzhen Qian, Caixia Deng, Jiayi Qin, Xiangdong Zhou, Hu Luo. Prognostic nomogram and epidemiological analysis for lung atypical carcinoid: A SEER database and external validation study.Cancer medicine. 2023, :
12)- . Correction to "Assessment of organization of cervical and breast cancer screening programmes in the Latin American and the Caribbean states: The CanScreen5 framework".Cancer medicine. 2023, :
14)- Katharina Och, Amin T Turki, Katharina M Götz, Dominik Selzer, Christian Brossette, Stefan Theobald, Yvonne Braun, Norbert Graf, Jochen Rauch, Kerstin Rohm, Gabriele Weiler, Stephan Kiefer, Ulf Schwarz, Lisa Eisenberg, Nico Pfeifer, Matthias Ihle, Andrea Grandjean, Sonja Fix, Claudia Riede, Jürgen Rissland, Sigrun Smola, Dietrich W Beelen, Dominic Kaddu-Mulindwa, Jörg Bittenbring, Thorsten Lehr. A dynamic time-to-event model for prediction of acute graft-versus-host disease in patients after allogeneic hematopoietic stem cell transplantation.Cancer medicine. 2023, :
18)- Yongzhen Li, Zhongying Lu, Ao Ma, Wei Yao, Rui Dong, Kai Li, Min Wu, Kuiran Dong, Tian Qian. Nutritional status associated with clinical outcomes in children with solid tumors: A retrospective cohort study from China.Cancer medicine. 2023, :
24)- Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck. The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer.Cancer medicine. 2023, :
26)- Deniz Can Guven, Musa Baris Aykan, Harun Muglu, Ertugrul Bayram, Kaan Helvaci, Bengü Dursun, Melisa Celayir, Elvin Chelebiyev, Erdinc Nayir, Mustafa Erman, Ahmet Sezer, Yuksel Urun, Umut Demirci, Ozlem Er, Umut Disel, Ahmet Bilici, Cagatay Arslan, Nuri Karadurmus, Saadettin Kilickap. The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study.Cancer medicine. 2023, :
27)- Wei-Li Ma, Ruey-Long Hong, Pei-Jen Lou, Ming Yao, Shang-Ju Wu, Chung-Wu Lin, Chun-Wei Wang, Chin-Hao Chang, Ann-Lii Cheng, Sung-Hsin Kuo. Improved outcomes of localized diffuse large B-cell lymphoma at the Waldeyer ring in comparison to the sinonasal area in the rituximab era.Cancer medicine. 2023, :
29)- Hao Zhang, Jingtong Zeng, Xianjie Li, Bo Zhang, Hanqing Wang, Quanying Tang, Yifan Zhang, Shihao Bao, Lingling Zu, Xiaohong Xu, Song Xu, Zuoqing Song. The nomogram for the prediction of overall survival after surgery in patients in early-stage NSCLC based on SEER database and external validation cohort.Cancer medicine. 2023, :
30)- Avinash Maganty, Samuel R Kaufman, Mary K Oerline, Kassem S Faraj, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck. Value-based payment models and management of newly diagnosed prostate cancer.Cancer medicine. 2023, :
31)- Omid Yazdanpanah, Aditya Mahadevan, Aditi Sharma, David J Benjamin, Arash Rezazadeh Kalebasty. A comparative study of spinal cord compression management in metastatic prostate cancer: Teaching versus non-teaching hospitals in the United States.Cancer medicine. 2023, :
33)- Hiroyuki Arai, Madoka Takeuchi, Wataru Ichikawa, Kohei Shitara, Yu Sunakawa, Koji Oba, Wasaburo Koizumi, Yuh Sakata, Hiroshi Furukawa, Yasuhide Yamada, Masahiro Takeuchi, Masashi Fujii. Correlation of multiple endpoints in the first-line chemotherapy of advanced gastric cancer: Pooled analysis of individual patient data from Japanese Phase III trials.Cancer medicine. 2023, :
34)- Saryleine de Ortiz de Choudens, Alexis Visotcky, Anjishnu Banerjee, Mohammed Aldakkak, Susan Tsai, Douglas B Evans, Kathleen K Christians, Callisia N Clarke, Ben George, Aditya Shreenivas, Mandana Kamgar, Sakti Chakrabarti, Kulwinder S Dua, Abdul Haq Khan, Srivats Madhavan, Beth A Erickson, William A Hall. Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy.Cancer medicine. 2023, :
35)- Bo Wang, Lu Wang, Runshi Shang, Lin Xie. MDSC suppresses T cell antitumor immunity in CAC via GPNMB in a MyD88-dependent manner.Cancer medicine. 2023, :
36)- Marie Fefferman, Kristine Kuchta, Chi-Hsiung Wang, Kyra Nicholson, Katherine Kopkash, Catherine Pesce, Elizabeth Poli, Thomas W Smith, Katharine Yao. Rates of newly diagnosed breast cancer at commission on cancer facilities during the early phase of the COVID-19 pandemic.Cancer medicine. 2023, :
38)- Tibor A Zwimpfer, Kathrin Scherer, Andreas Schötzau, Viola Heinzelmann-Schwarz, Karin Hartmann, Marcus Vetter, Céline Montavon. Desensitization in patients with hypersensitivity to platinum and taxane in gynecological cancers.Cancer medicine. 2023, :
39)- Hassam Ali, Pratik Patel, Dushyant Singh Dahiya, Manesh Kumar Gangwani, Debargha Basuli, Babu Pappu Mohan. Prediction of early-onset colorectal cancer mortality rates in the United States using machine learning.Cancer medicine. 2023, :
40)- Richard A Taylor, Marie Bakitas, Rachel Wells, J Nicholas Dionne-Odom, Richard Kennedy, Grant R Williams, Jennifer Frank, Peng Li. Restricted life-space mobility impacts physical but not mental quality of life in older cancer survivors.Cancer medicine. 2023, :
41)- Yan Hiu Athena Lee, Jeffrey Shi Kai Chan, Jeremy Man Ho Hui, Pias Tang, Kang Liu, Edward Christopher Dee, Kenrick Ng, Gary Tse, Chi Fai Ng. Statin use and mortality risk in Asian patients with prostate cancer receiving androgen deprivation therapy: A population-based cohort study.Cancer medicine. 2023, :
44)- Wenjing Wang, Jing Li, Yang Yang, Feifei Chen, Tianhong Xu, Pu Wang, Yawen Wang, Aziguli Maihemaiti, Liang Ren, Tianwei Lan, Panpan Li, Chi Zhou, Peng Liu. Update on the outcome of M-protein screening program of multiple myeloma in China: A 7-year cohort study.Cancer medicine. 2023, :
46)- Mariam Zahwe, Aya El Sammak, Karim Ataya, Christelle Jabbour, Ayman Bsat, Bassel Hafez, Christine Atallah, Mira Kheil, Mohamad Ali Maktabi, Bashar Hassan, Vahe Panossian, Hazem Assi, Jaber Abbas, Eman Sbaity. Performance and oncologic safety of sentinel lymph node biopsy after neoadjuvant chemotherapy: Results from a tertiary care center in Lebanon.Cancer medicine. 2023, :
47)- Thomas Bardol, Zahra Eslami-S, Doryan Masmoudi, Marie Alexandre, Marie Duboys de Labarre, Angélique Bobrie, Véronique D'Hondt, Séverine Guiu, Keerthi Kurma, Laure Cayrefourcq, William Jacot, Catherine Alix-Panabières. First evidence of AXL expression on circulating tumor cells in metastatic breast cancer patients: A proof-of-concept study.Cancer medicine. 2023, :
49)- Jungah Lim, Razelle Kurzrock, Daisuke Nishizaki, Hirotaka Miyashita, Jacob J Adashek, Suzanna Lee, Sarabjot Pabla, Mary Nesline, Jeffrey M Conroy, Paul DePietro, Scott M Lippman, Shumei Kato. Pan-cancer analysis of TIM-3 transcriptomic expression reveals high levels in pancreatic cancer and interpatient heterogeneity.Cancer medicine. 2023, :
50)- Tamás Dániel Csűry, Anna Zsófia Csűry, Matthias Balk, Andreas M Kist, Robin Rupp, Sarina K Mueller, Matti Sievert, Heinrich Iro, Markus Eckstein, Antoniu-Oreste Gostian. The modified Polsby-Popper score, a novel quantitative histomorphological biomarker and its potential to predict lymph node positivity and cancer-specific survival in oral tongue squamous cell carcinoma.Cancer medicine. 2023, :